Viridian Therapeutics Market Cap

Viridian Therapeutics has a market cap or net worth of $808.45 million as of April 26, 2024. Its market cap has decreased by -35.53% in one year.

Market Cap

808.45M

Enterprise Value

351.28M

1-Year Change

-35.53%

Ranking

#2576

Market Cap Chart

Since June 18, 2014, Viridian Therapeutics's market cap has increased from $34.70M to $808.45M, an increase of 2,229.82%. That is a compound annual growth rate of 37.62%.

Market Cap History

Date	Market Cap	% Change
Apr 25, 2024	797.10M	-2.54%
Apr 24, 2024	817.90M	-8.55%
Apr 23, 2024	894.40M	-0.36%
Apr 22, 2024	897.60M	-2.05%
Apr 19, 2024	916.40M	-3.70%
Apr 18, 2024	951.60M	0.54%
Apr 17, 2024	946.50M	-0.07%
Apr 16, 2024	947.20M	-3.51%
Apr 15, 2024	981.70M	-1.57%
Apr 12, 2024	997.40M	-1.98%
Apr 11, 2024	1.02B	0.62%
Apr 10, 2024	1.01B	-4.39%
Apr 9, 2024	1.06B	-0.30%
Apr 8, 2024	1.06B	3.55%
Apr 5, 2024	1.02B	-
Apr 4, 2024	1.02B	0.37%
Apr 3, 2024	1.02B	-2.58%
Apr 2, 2024	1.05B	-3.30%
Apr 1, 2024	1.08B	-1.43%
Mar 28, 2024	1.10B	-
Mar 27, 2024	1.10B	0.81%
Mar 26, 2024	1.09B	-1.03%
Mar 25, 2024	1.10B	-2.55%
Mar 22, 2024	1.13B	-4.11%
Mar 21, 2024	1.18B	3.76%

View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Relay Therapeutics	832.99M
Tango Therapeutics	828.13M
Healthcare Services Group	825.60M
EyePoint Pharmaceuticals	820.71M
Enliven Therapeutics	818.63M
National Research	817.49M
Canopy Growth	817.30M
Nurix Therapeutics	815.62M

Market Cap Rankings